期刊
JOURNAL OF PHARMACEUTICAL SCIENCES
卷 111, 期 4, 页码 933-950出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.xphs.2021.12.011
关键词
Biopharmaceutical characterization; Lipid Nanoparticle(s) (LNP); Microparticle(s); Nanoparticle(s); Particle size; Protein(s); Protein aggregation; Protein formulation(s); Vaccine(s); Viral vector(s)
Particles in biopharmaceutical formulations have been a hot topic in drug product development. This review provides a comprehensive overview of novel particle analysis techniques for particulate impurities in therapeutic protein formulations and biopharmaceutical formulations, discussing their applications, specific analytical approaches, and the advantages and drawbacks of currently available techniques.
Particles in biopharmaceutical formulations remain a hot topic in drug product development. With new product classes emerging it is crucial to discriminate particulate active pharmaceutical ingredients from particulate impurities. Technical improvements, new analytical developments and emerging tools (e.g., machine learning tools) increase the amount of information generated for particles. For a proper interpretation and judgment of the generated data a thorough understanding of the measurement principle, suitable application fields and potential limitations and pitfalls is required. Our review provides a comprehensive overview of novel particle analysis techniques emerging in the last decade for particulate impurities in therapeutic protein formulations (protein-related, excipient-related and primary packaging material-related), as well as particulate biopharmaceutical formulations (virus particles, virus-like particles, lipid nanoparticles and cell based medicinal products). In addition, we review the literature on applications, describe specific analytical approaches and illustrate advantages and drawbacks of currently available techniques for particulate biopharmaceutical formulations.(c) 2021 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据